Allana J. Sucher

545 total citations
13 papers, 404 citations indexed

About

Allana J. Sucher is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Allana J. Sucher has authored 13 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Infectious Diseases and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Allana J. Sucher's work include Antifungal resistance and susceptibility (3 papers), Respiratory and Cough-Related Research (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Allana J. Sucher is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Respiratory and Cough-Related Research (3 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Allana J. Sucher collaborates with scholars based in United States. Allana J. Sucher's co-authors include Elias B. Chahine, Stephanie James, Brian A. Hemstreet, John A. Dougherty, Katherine C Shihadeh and Michael Nelson and has published in prestigious journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy and The Consultant Pharmacist.

In The Last Decade

Allana J. Sucher

13 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allana J. Sucher United States 9 183 180 77 74 48 13 404
Juping Duan China 11 192 1.0× 124 0.7× 165 2.1× 39 0.5× 75 1.6× 15 543
José Luís López-Hontangas Spain 12 366 2.0× 383 2.1× 81 1.1× 49 0.7× 80 1.7× 38 681
Elena Orsetti Italy 12 289 1.6× 210 1.2× 99 1.3× 20 0.3× 26 0.5× 15 434
Varsha Moudgal United States 9 398 2.2× 316 1.8× 166 2.2× 89 1.2× 96 2.0× 18 649
Alejandro Pironti United States 12 153 0.8× 120 0.7× 181 2.4× 61 0.8× 247 5.1× 37 569
Lori Banks United States 9 118 0.6× 104 0.6× 135 1.8× 70 0.9× 150 3.1× 11 440
Hsiang‐Chi Kung Taiwan 14 234 1.3× 284 1.6× 25 0.3× 39 0.5× 47 1.0× 22 392
MaryBeth Frosco United States 13 165 0.9× 135 0.8× 117 1.5× 124 1.7× 78 1.6× 19 473
R. G. Finch United Kingdom 9 101 0.6× 148 0.8× 72 0.9× 66 0.9× 41 0.9× 19 421
Herbert Houck United States 12 289 1.6× 304 1.7× 161 2.1× 60 0.8× 84 1.8× 22 731

Countries citing papers authored by Allana J. Sucher

Since Specialization
Citations

This map shows the geographic impact of Allana J. Sucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allana J. Sucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allana J. Sucher more than expected).

Fields of papers citing papers by Allana J. Sucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allana J. Sucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allana J. Sucher. The network helps show where Allana J. Sucher may publish in the future.

Co-authorship network of co-authors of Allana J. Sucher

This figure shows the co-authorship network connecting the top 25 collaborators of Allana J. Sucher. A scholar is included among the top collaborators of Allana J. Sucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allana J. Sucher. Allana J. Sucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sucher, Allana J., et al.. (2022). PreHevbrio: A New 3-Antigen Hepatitis B Vaccine for Adults. Annals of Pharmacotherapy. 57(3). 325–332. 3 indexed citations
2.
Sucher, Allana J., et al.. (2022). Ibrexafungerp: A new triterpenoid antifungal. American Journal of Health-System Pharmacy. 79(24). 2208–2221. 13 indexed citations
3.
Sucher, Allana J., et al.. (2020). A review of coronavirus disease 2019 (COVID-19) for pharmacists. ePublications at Regis University (Regis University). 1 indexed citations
4.
Chahine, Elias B. & Allana J. Sucher. (2020). Lefamulin: The First Systemic Pleuromutilin Antibiotic. Annals of Pharmacotherapy. 54(12). 1203–1214. 18 indexed citations
5.
James, Stephanie, et al.. (2018). Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine. Annals of Pharmacotherapy. 52(7). 673–680. 88 indexed citations
6.
Dougherty, John A., Allana J. Sucher, Elias B. Chahine, & Katherine C Shihadeh. (2018). Omadacycline: A New Tetracycline Antibiotic. Annals of Pharmacotherapy. 53(5). 486–500. 27 indexed citations
7.
Chahine, Elias B., Allana J. Sucher, & Brian A. Hemstreet. (2016). Sofosbuvir/Velpatasvir. Annals of Pharmacotherapy. 51(1). 44–53. 27 indexed citations
8.
Chahine, Elias B., et al.. (2015). Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections. The Consultant Pharmacist. 30(7). 386–394. 10 indexed citations
9.
Sucher, Allana J., et al.. (2015). Ceftolozane/Tazobactam. Annals of Pharmacotherapy. 49(9). 1046–1056. 30 indexed citations
10.
Chahine, Elias B., et al.. (2014). Fidaxomicin: A Novel Macrolide Antibiotic for <I>Clostridium difficile</I> Infection. The Consultant Pharmacist. 29(9). 614–624. 2 indexed citations
11.
Chahine, Elias B., et al.. (2014). Fidaxomicin: a novel macrolide antibiotic for Clostridium difficile infection.. PubMed. 29(9). 614–24. 4 indexed citations
12.
Sucher, Allana J., et al.. (2011). Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine. Annals of Pharmacotherapy. 45(12). 1516–1524. 25 indexed citations
13.
Sucher, Allana J., et al.. (2009). Echinocandins: The Newest Class of Antifungals. Annals of Pharmacotherapy. 43(10). 1647–1657. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026